Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Antonio Bayés de Luna , Albert Massó-van Roessel , Luis Alberto Escobar Robledo Added: 3 years ago
It has been considered that an interatrial block exists when there is a delay of conduction in some part of the Bachmann’s bundle zone.1 The interatrial blocks are the most frequent and well-known blocks at atrial level. These are expressed in the electrocardiogram (ECG) by the presence of a P wave duration that equals or exceeds 120 milliseconds and presents usually a bimodal morphology,… View more
Author(s): Velislav N Batchvarov Added: 3 years ago
The two most important, both medically and socially, cardiac arrhythmic problems of our time are sudden cardiac death due to ventricular fibrillation (VF) (mainly in the setting of coronary artery disease) and atrial fibrillation (AF). For both of them, the identification of electrocardiogram ( ECG) markers that can reliably predict the occurrence of the arrhythmia is generally an unresolved… View more
Job title: Director of the Structural Heart Disease Program
Job title: Podiatric Surgeon
Author(s): Robert Campbell , Peter Fischbach , Patricio Frias , et al Added: 3 years ago
White and Eustis were the first to document congenital complete heart block (CCHB) with electrocardiogram in 1921. Until the 1950s, CCHB without structural heart disease was considered rare and benign. CCHB is estimated to complicate one in 15,000–22,000 live births; however, the true incidence of CCHB is unknown as there is an association with structural congenital heart disease (CHD) with a… View more
Author(s): Anna E Platek , Anna Hrynkiewicz-Szymanska , Karolina Semczuk , et al Added: 3 years ago
Young Investigator Award Topic: 4. Arrhythmias Introduction and Objectives Guidelines of the European Society of Cardiology (ESC) from 2016 recommend pre-treatment with non- antiarrhythmic drugs (namely ACE-Is or ARBs) in patients with recurrent atrial fibrillation (AF), in whom rhythm control strategy is considered.1 This recommendation is based on possible antiarrhythmic effects of these… View more
Author(s): Lars H Lund Added: 1 year ago
Prof Lars Lund (Karolinska Institute, SE) outlines the findings of the ALLEVIATE-HF-1 and ALLEVIATE-HF-2 studies at 6 months. Presented at Heart Failure 22, this study aimed to evaluate a no-implant shunt in patients with chronic heart failure. Discussion Points: 1. Aims of This Study 2. No-Implant Interatrial Shunt 3. Inclusion and Exclusion Criteria, Patient Cohort and Study Design 4. Key… View more
Author(s): Cristoph Hasslacher Added: 3 years ago
The prognosis for diabetics with renal insufficiency is still unfavourable even today. The five-year survival of dialysis patients with type 2 diabetes is approximately 30% and as such resembles the life expectancy resulting from a malignant gastrointestinal tumour. The poor prognosis is based on the excessively high cardiovascular morbidity and mortality of these patients whose cause cannot be… View more